Literature DB >> 12500286

Abnormal angiogenesis in diabetes mellitus.

Alexandra Martin1, Michael R Komada, David C Sane.   

Abstract

The adverse long-term effects of diabetes mellitus have been well described and involve many organ systems. While diabetes management has largely focused on control of hyperglycemia, the presence of abnormalities of angiogenesis may cause or contribute to many of the clinical manifestations of diabetes. When compared with non-diabetic subjects, diabetics demonstrate vascular abnormalities of the retina, kidneys, and fetus. Diabetics have impaired wound healing, increased risk of rejection of transplanted organs, and impaired formation of coronary collaterals. In each of these conditions, and possibly in diabetic neuropathy as well, abnormalities of angiogenesis can be implicated in the pathogenesis. A perplexing feature of the aberrant angiogenesis is that excessive and insufficient angiogenesis can occur in different organs in the same individual. In this review, the clinical features, molecular mechanisms, and potential therapeutic options of abnormal angiogenesis in diabetes will be reviewed. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12500286     DOI: 10.1002/med.10024

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  151 in total

1.  Sprouty2 downregulates angiogenesis during mouse skin wound healing.

Authors:  Mateusz S Wietecha; Lin Chen; Matthew J Ranzer; Kimberly Anderson; Chunyi Ying; Tarun B Patel; Luisa A DiPietro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

Review 2.  Angiogenesis in diabetes and obesity.

Authors:  Rui Cheng; Jian-xing Ma
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

3.  Endothelial alpha1-adrenoceptors regulate neo-angiogenesis.

Authors:  M Ciccarelli; G Santulli; A Campanile; G Galasso; P Cervèro; G G Altobelli; V Cimini; L Pastore; F Piscione; B Trimarco; G Iaccarino
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

Review 4.  Polymers to direct cell fate by controlling the microenvironment.

Authors:  R Warren Sands; David J Mooney
Journal:  Curr Opin Biotechnol       Date:  2007-10       Impact factor: 9.740

5.  A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes.

Authors:  Carmen M Warren; Safiyyah Ziyad; Anaïs Briot; Aaron Der; M Luisa Iruela-Arispe
Journal:  Sci Signal       Date:  2014-01-07       Impact factor: 8.192

6.  miR-25 and miR-92a regulate insulin I biosynthesis in rats.

Authors:  Dwi Setyowati Karolina; Sugunavathi Sepramaniam; Hui Zhing Tan; Arunmozhiarasi Armugam; Kandiah Jeyaseelan
Journal:  RNA Biol       Date:  2013-08       Impact factor: 4.652

Review 7.  Therapeutic Approaches to the Regulation of Wound Angiogenesis.

Authors:  Mateusz S Wietecha; Luisa A DiPietro
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-04       Impact factor: 4.730

Review 8.  MicroRNAs in diabetic wound healing: Pathophysiology and therapeutic opportunities.

Authors:  Denizhan Ozdemir; Mark W Feinberg
Journal:  Trends Cardiovasc Med       Date:  2018-08-08       Impact factor: 6.677

9.  Small molecule inhibition of dipeptidyl peptidase-4 enhances bone marrow progenitor cell function and angiogenesis in diabetic wounds.

Authors:  Alexander J Whittam; Zeshaan N Maan; Dominik Duscher; Janos A Barrera; Michael S Hu; Lauren H Fischer; Sacha Khong; Sun Hyung Kwon; Victor W Wong; Graham G Walmsley; Ferdinando Giacco; Michael Januszyk; Michael Brownlee; Michael T Longaker; Geoffrey C Gurtner
Journal:  Transl Res       Date:  2018-11-02       Impact factor: 7.012

10.  Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women.

Authors:  Y Yu; A J Jenkins; A J Nankervis; K F Hanssen; H Scholz; T Henriksen; B Lorentzen; T Clausen; S K Garg; M K Menard; S M Hammad; J C Scardo; J R Stanley; A Dashti; K May; K Lu; C E Aston; J J Wang; S X Zhang; J-X Ma; T J Lyons
Journal:  Diabetologia       Date:  2008-11-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.